European equities traded in the US as American depositary receipts were little changed late Tuesday morning, edging 0.01% higher to 1,839.63 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet advertising firm Criteo (CRTO) and biopharmaceutical company DBV Technologies (DBVT), which rose 2.6% and 2.1%, respectively. They were followed by biotech firm Evaxion (EVAX) and pharmaceutical company Sanofi (SNY), which were up 1.9% and 1.1%, respectively.

The decliners from continental Europe were led by telecommunications operator Telefonica (TELFY) and pharmaceutical company Novo Nordisk (NVO), which dropped 3.8% and 2.4%, respectively. They were followed by lender Banco Santander (SAN) and telecommunications company Nokia (NOK), which lost 1.9% and 1.7%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which advanced 7.8% and 6.1%, respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company NuCana (NCNA), which increased 5.5% and 5.1%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and lender Lloyds Banking Group (LYG), which fell 2.9% and 1.3%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and tobacco company British American Tobacco (BTI), which were down 1.1% and 0.9%.